Millions of women taking semaglutide or similar GLP-1 receptor agonists for diabetes and obesity now have a new data point to ...

Cancer is a significant global health concern and is the second leading cause of death worldwide 1. In 2022 alone, an estimated 20 million new cases were diagnosed, and tragically, 9.7 million ...

As people continue to live longer and the survival rate of cancer diagnoses increases, researchers from VCU Massey Comprehensive Cancer Center led a multi-decade analysis studying the rates of ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...

People without a family history of risk are generally advised to start colorectal cancer screening at around age 50, as it ...

Obesity is a major health challenge. Here we show that body mass index is positively associated with risk of 19 cancers and inversely associated with 3, based on a systematic review and meta-analysis ...

The authors of the new meta-analysis aimed to provide an update on the association between ankylosing spondylitis and cancer incidence. “While the etiology of ankylosing spondylitis remains elusive, ...

This is a retrospective study of patients with metastatic Pca, diagnosed at King Hussein Cancer Center, Jordan, between 2006 and 2018. Survival was estimated using the Kaplan-Meier method and compared ...

Real-world ASCO data link GLP-1 drugs to markedly longer survival across common cancers, raising new questions on mechanism and trials. Patients with cancer who used glucagon-like peptide-1 receptor ...

A few blocks away, even closer to the contaminated landfill, lives a man with chronic myeloid leukemia, in remission after a ...

Objectives To examine the association between muscle strength and cardiorespiratory fitness (CRF) with all-cause and cancer-specific mortality in patients diagnosed with cancer, and whether these ...